TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 1 | -1 | -1 | 7 | 23 | 1 | 5 |
| P | %wins | 50 | 0 | 50 | 50 | 100 | 50 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/7/16 14:10 | 3/3/16 | NVET | Nexvet Biopharma Plc | L2 | Health | Drug | Pharmaceutical Preparations | Gearing David | L2 | O | CHIEF SC | P.m | 37 | 3.33 | 0 | 11 | 3 | 411 | I | -68 | -23 | -11 | 1 | 5 | 8 | -2 | 2 | -1 | 2 | 21 | 22 | 4 | |
3/1/16 14:00 | 2/25/16 | NVET | Nexvet Biopharma Plc | L2 | Health | Drug | Pharmaceutical Preparations | Gearing David | L2 | O | Chief Sc | P.m | 103 | 3.32 | 0 | 31 | 8 | 400 | I | -66 | -33 | -16 | -5 | 6 | 10 | 11 | -1 | -1 | -3 | -7 | 24 | -2 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |